AAAAAA
Results: 1-25/27
Authors:
BUCKE WE
LEITZKE S
DIEDERICHS JE
BORNER K
HAHN H
EHLERS S
MULLER RH
Citation: We. Bucke et al., SURFACE-MODIFIED AMIKACIN-LIPOSOMES - ORGAN DISTRIBUTION AND INTERACTION WITH PLASMA-PROTEINS, Journal of drug targeting., 5(2), 1998, pp. 99-108
Authors:
LODE H
BORNER K
KOEPPE P
Citation: H. Lode et al., PHARMACODYNAMICS OF FLUOROQUINOLONES, Clinical infectious diseases, 27(1), 1998, pp. 33-39
Authors:
STAHLMANN R
ZIPPEL U
FORSTER C
SCHWABE R
SHAKIBAEI M
MERKER HJ
BORNER K
Citation: R. Stahlmann et al., CHONDROTOXICITY AND TOXICOKINETICS OF SPARFLOXACIN IN JUVENILE RATS, Antimicrobial agents and chemotherapy, 42(6), 1998, pp. 1470-1475
Authors:
LEITZKE S
BUCKE W
BORNER K
MULLER R
HAHN H
EHLERS S
Citation: S. Leitzke et al., RATIONALE FOR AND EFFICACY OF PROLONGED-INTERVAL TREATMENT USING LIPOSOME-ENCAPSULATED AMIKACIN IN EXPERIMENTAL MYCOBACTERIUM-AVIUM INFECTION, Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 459-461
Authors:
BORNER K
Citation: K. Borner, WEST MEETS EAST - CLASSIC BOOKS WRITTEN BY BRITISH TRAVELERS TO THE ORIENT - GERMAN - BODE,C, Zeitschrift fur Anglistik und Amerikanistik, 46(3), 1998, pp. 264-265
Authors:
BORNER K
BORNER E
LODE H
Citation: K. Borner et al., SEPARATION OF LANSOPRAZOLE ENANTIOMERS IN HUMAN SERUM BY HPLC, Chromatographia, 47(3-4), 1998, pp. 171-175
Authors:
ECKHARDT A
BORNER K
KELLER F
ZELLNER D
Citation: A. Eckhardt et al., DOSAGE ADJUSTMENT OF ANTIINFECTIVE THERAPY IN PATIENTS WITH RENAL IMPAIRMENT, International journal of clinical pharmacology and therapeutics, 35(3), 1997, pp. 99-102
Authors:
SCHULER P
ZEMPER K
BORNER K
KOEPPE P
SCHABERG T
LODE H
Citation: P. Schuler et al., PENETRATION OF SPARFLOXACIN AND CIPROFLOXACIN INTO ALVEOLAR MACROPHAGES, EPITHELIAL LINING FLUID, AND POLYMORPHONUCLEAR LEUKOCYTES, The European respiratory journal, 10(5), 1997, pp. 1130-1136
Authors:
ZIX JA
GEERDESFENGE HF
RAU M
VOCKLER J
BORNER K
KOEPPE P
LODE H
Citation: Ja. Zix et al., PHARMACOKINETICS OF SPARFLOXACIN AND INTERACTION WITH CISAPRIDE AND SUCRALFATE, Antimicrobial agents and chemotherapy, 41(8), 1997, pp. 1668-1672
Authors:
GEERDESFENGE HF
GOETSCHI B
RAU M
BORNER K
KOEPPE P
WETTICH K
LODE H
Citation: Hf. Geerdesfenge et al., COMPARATIVE PHARMACOKINETICS OF DIRITHROMYCIN AND ERYTHROMYCIN IN NORMAL VOLUNTEERS WITH SPECIAL REGARD TO ACCUMULATION IN POLYMORPHONUCLEAR LEUKOCYTES AND IN SALIVA, European Journal of Clinical Pharmacology, 53(2), 1997, pp. 127-133
Authors:
MAINZ D
BORNER K
KOEPPE P
FUCHS W
KADUS W
LODE H
Citation: D. Mainz et al., PHARMACOKINETICS OF LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN WHENGIVEN SIMULTANEOUSLY, Gut, 41, 1997, pp. 96-96
Authors:
BORNER K
BORNER E
LODE H
Citation: K. Borner et al., QUANTITATIVE-DETERMINATION OF LANSOPRAZOLE IN HUMAN SERUM BY HPLC, Chromatographia, 45, 1997, pp. 450-452
Authors:
LODE H
BORNER K
KOEPPE P
SCHABERG T
Citation: H. Lode et al., AZITHROMYCIN - REVIEW OF KEY CHEMICAL, PHARMACOKINETIC AND MICROBIOLOGICAL FEATURES, Journal of antimicrobial chemotherapy, 37, 1996, pp. 1-8
Authors:
TRAUTMANN M
RUHNKE M
BORNER K
WAGNER J
KOEPPE P
Citation: M. Trautmann et al., PHARMACOKINETICS OF SPARFLOXACIN AND SERUM BACTERICIDAL ACTIVITY AGAINST PNEUMOCOCCI, Antimicrobial agents and chemotherapy, 40(3), 1996, pp. 776-779
Authors:
DREETZ M
HAMACHER J
ELLER J
BORNER K
KOEPPE P
SCHABERG T
LODE H
Citation: M. Dreetz et al., SERUM BACTERICIDAL ACTIVITIES AND COMPARATIVE PHARMACOKINETICS OF MEROPENEM AND IMIPENEM-CILASTATIN, Antimicrobial agents and chemotherapy, 40(1), 1996, pp. 105-109
Authors:
STAHLMANN R
ZIPPEL U
FORSTER C
BORNER K
Citation: R. Stahlmann et al., CONCENTRATIONS OF SPARFLOXACIN IN PLASMA, CARTILAGE AND BONE OF IMMATURE RATS AT CHONDROTOXIC AND NON-CHONDROTOXIC DOSES, Naunyn-Schmiedeberg's archives of pharmacology, 354(4), 1996, pp. 97-97
Authors:
BORNER K
Citation: K. Borner, STOCKMEIER 'KONZERT FUR ORGELPOSITIV UND STREICHORCHESTER', Musik und Kirche, 66(5), 1996, pp. 324-324
Authors:
KELLER F
ECKHARDT A
BORNER K
Citation: F. Keller et al., RENAL-INSUFFICIENCY, PHARMACOKINETIC DOSE ADJUSTMENT AND THE THERAPEUTIC DRUG-MONITORING OF ANTIINFECTIVE THERAPIES, Kidney international, 47(3), 1995, pp. 982-982
Authors:
LODE H
SCHABERG T
HOFFKEN G
BORNER K
Citation: H. Lode et al., USE OF FLUOROQUINOLONES IN LOWER RESPIRATORY-TRACT INFECTIONS (LRTI), International journal of antimicrobial agents, 4, 1994, pp. 190000047-190000052
Authors:
KELLER F
HORSTENSMEYER C
LOOBY M
BORNER K
POMMER W
ERDMANN K
GIEHL M
Citation: F. Keller et al., VANCOMYCIN DOSING IN HEMODIALYSIS-PATIENTS AND BAYESIAN ESTIMATE OF INDIVIDUAL PHARMACOKINETIC PARAMETERS, International journal of artificial organs, 17(1), 1994, pp. 19-26
Authors:
RITZ M
LODE H
FASSBENDER M
BORNER K
KOEPPE P
NORD CE
Citation: M. Ritz et al., MULTIPLE-DOSE PHARMACOKINETICS OF SPARFLOXACIN AND ITS INFLUENCE ON FECAL FLORA, Antimicrobial agents and chemotherapy, 38(3), 1994, pp. 455-459
Authors:
LODE H
FASSBENDER M
SCHABERG T
BORNER K
KOEPPE P
Citation: H. Lode et al., COMPARATIVE PHARMACOKINETICS OF THE NEW ORAL CEPHALOSPORINS, Drugs, 47, 1994, pp. 10-20
Authors:
FASSBENDER M
LODE H
SCHABERG T
BORNER K
KOEPPE P
Citation: M. Fassbender et al., PHARMACOKINETICS OF NEW ORAL CEPHALOSPORINS, INCLUDING A NEW CARBACEPHEM, Clinical infectious diseases, 16(5), 1993, pp. 646-653
Authors:
BORNER K
BORNER E
LODE H
Citation: K. Borner et al., DETERMINATION OF A NEW CEPHALOSPORIN, SCE-2787, IN SERUM AND URINE BYHIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography. Biomedical applications, 615(1), 1993, pp. 174-179
Authors:
PAULFEUERBORN W
MULLER HJ
BORNER K
KOEPPE P
LODE H
Citation: W. Paulfeuerborn et al., COMPARATIVE PHARMACOKINETICS AND SERUM BACTERICIDAL ACTIVITIES OF SCE-2787 AND CEFTAZIDIME, Antimicrobial agents and chemotherapy, 37(9), 1993, pp. 1835-1841